Form 4 holding
Director
Hepion Pharmaceuticals, Inc.
- Security class
- Stock Options
- Shares / value
- 299,000
- Estimated value
- Report date
- 19 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount